Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.
about
Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growthImportance of Drug Pharmacokinetics at the Site of ActionEffects of Liposomes Charge on Extending Sciatic Nerve Blockade of N-ethyl Bromide of Lidocaine in Rats.RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery.Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses.Use of nanotechnology for improved pharmacokinetics and activity of immunogenic cell death inducers used in cancer chemotherapy.Advancement of the Emerging Field of RNA Nanotechnology.Enhancing the cytotoxicity of chemoradiation with radiation-guided delivery of anti-MGMT morpholino oligonucleotides in non-methylated solid tumors.Theranostic Liposome-Nanoparticle Hybrids for Drug Delivery and Bioimaging.Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer.The Effect of Size and Shape of RNA Nanoparticles on Biodistribution.γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion.Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing ratsSPIO-loaded nanostructured lipid carriers as liver-targeted molecular T2-weighted MRI contrast agentCucurbit[6]uril-based polymer nanocapsules as a non-covalent and modular bioimaging platform for multimodal in vivo imaging
P2860
Q33588245-29BF3BC2-62AB-43B2-9803-5E04C511C07AQ33648045-E40D2DF5-9E69-424D-8FD1-E7C8A2856F8EQ37479784-78A7056B-BA1A-4E21-91DD-2FE2017E31CCQ38728680-D5736E61-5F6E-4921-8146-5D6EB593C9AEQ38737582-7FCD62AE-4B25-4A8E-970A-0826A0FD2D4CQ38789551-5E0D868B-DFDE-418F-9FFB-9533E76D3D96Q39065708-3EBDCDF4-E6ED-4133-87CD-11C0D1C04D85Q40104372-4B0B5FE7-229A-4A1C-A174-0F69B883B5CCQ41181847-13BC8C06-85DD-464C-8E43-14C77187A137Q47311101-77A26280-9ED8-4A72-A227-53153E647F76Q50061940-D4599620-21B9-46B3-9348-EDD1CF253EC1Q55413334-CA422D47-CF29-4355-A5C7-10320A7F82B7Q57022278-BF2590E3-8A3C-4226-B444-6574C459AF7FQ57300757-95F7D0DD-1480-4611-B11B-A8DE96A8C4E6Q59197887-47897EC2-2E59-4EF9-9E95-7B676C3583D2
P2860
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Lipid-Based Drug Delivery Syst ...... lable and What Is Yet to Come.
@ast
Lipid-Based Drug Delivery Syst ...... lable and What Is Yet to Come.
@en
type
label
Lipid-Based Drug Delivery Syst ...... lable and What Is Yet to Come.
@ast
Lipid-Based Drug Delivery Syst ...... lable and What Is Yet to Come.
@en
prefLabel
Lipid-Based Drug Delivery Syst ...... lable and What Is Yet to Come.
@ast
Lipid-Based Drug Delivery Syst ...... lable and What Is Yet to Come.
@en
P2860
P356
P1476
Lipid-Based Drug Delivery Syst ...... lable and What Is Yet to Come.
@en
P2093
Phatsapong Yingchoncharoen
P2860
P304
P356
10.1124/PR.115.012070
P577
2016-07-01T00:00:00Z